Source: Business Insider
Vas Narasimhan, CEO of the pharma giant Novartis, joined Anthropic's board of directors in April. Hollie Adams/Bloomberg via Getty ImagesAnthropic is starting to think like a drugmaker. Anthropic's IPO filing outlines its ambitious plans for biological science.
Aller á la Source
Nouvelles connexes
